Last reviewed · How we verify
NCT04609436: SMARTTEL
SmartCardia Wireless Recorder as a Telemetry System
trial testing Cardiac monitoring with the wireless device "SmartCardia" in Arrhythmias, Cardiac in 50 participants. Completed in 1 February 2023.
1 March 2020
Quick facts
| Lead sponsor | University Hospital Freiburg |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 1 February 2020 |
| Primary completion | 1 March 2020 |
| Estimated completion | 1 February 2023 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Cardiac monitoring with the wireless device "SmartCardia"
Conditions studied
- Arrhythmias, Cardiac — all drugs for Arrhythmias, Cardiac →
- Monitoring — all drugs for Monitoring →
Sponsor
University Hospital Freiburg
Who can join
Adults 18 to 100, any sex, with Arrhythmias, Cardiac or Monitoring. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients hospitalized at the clinic Cecil who need telemetry will be monitored for 48 hours with the SmartCardia system in addition to conventional monitoring.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparison of Postoperative Continuous Wireless Cardiac Rhythm Monitoring with Traditional Telemetry in Cardiac Surgery Patients: the SMART-TEL Study.
Pidoux J, Conus E, Blackman N, Orrit J, et al · · 2024 · cited 2× · PMID 39193532 · DOI 10.19102/icrm.2024.15085
Verify or expand the search:
- PubMed search for NCT04609436
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Arrhythmias, Cardiac
Currently open trials in the same condition.
- NCT07276139 — PACEVALUE: Development of a Risk Score to Predict Pacing-Induced Cardiomyopathy in Patients Undergoing Pacemaker or ICD · active not recruiting
- NCT06954610 — Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation · recruiting
- NCT06360939 — Radiotherapy vs Catheter Ablation for Ventricular Tachycardia in Structural Heart Disease · NA · recruiting
- NCT06890208 — Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave · recruiting
- NCT06358391 — To Compare and Evaluate the Efficacy and Safety Between TS-RF System and BRK Transseptal Needles Used for Transseptal Pu · NA · recruiting
Other University Hospital Freiburg trials
Trials by the same sponsor.
- NCT07359313 — Incidence of Colon Ischemia in Patients After Cardiopulmonary Resuscitation (CPR) · NA · not yet recruiting
- NCT07082322 — European Prospective Bloodstream Infection Cohort · not yet recruiting
- NCT06156644 — Pulsed-Field-Ablation to Treat Atrial fiBRillation With a novEl multimodalIty Generator · NA · not yet recruiting
- NCT06576934 — Early TIPS in Patients With Liver Cirrhosis and Ascites · NA · recruiting
- NCT06711731 — The Freiburg Registry on SpontanEous IntercrAnial Hypotension (SIH) & Post-duraL Puncture Headache (PDPH) · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04609436 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital Freiburg
- Last refreshed: 8 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04609436.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing